Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis Publication Population pharmacokinetic model of ivermectin in mass drug administration against lymphatic filariasis Find out how sex affects ivermectin peripheral distribution; infection status does not, modelled using Phoenix…CertaraJune 1, 2023
American College of Toxicology 2026 Annual Meeting Conference American College of Toxicology 2026 Annual Meeting – – BoothKevin Snyder, PhDMay 24, 2023
Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease Case Study Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…CertaraMay 9, 2023
Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes Publication Effects of plateau hypoxia on population pharmacokinetics and pharmacodynamics of metformin in patients with Type 2 diabetes Explore how high‑altitude hypoxia increases metformin AUC and half‑life; PK‑PD modelling supports extended dosing intervals.CertaraApril 28, 2023
Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study Publication Optimization of polymyxin B regimens for the treatment of carbapenem-resistant organism nosocomial pneumonia: a real-world prospective study Discover how AUC/MIC ≥ 66.9 predicts efficacy; modelling supports 75–100 mg q12h dosing for CRO…CertaraApril 28, 2023
Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150 Publication Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150 Explore how tumor growth inhibition modeling can support go/no-go decisions in early Phase Ib/II oncology…CertaraMarch 24, 2023
Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans Publication Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans See how tablet and capsule are bioequivalent; food delays Tmax without affecting exposure, analysed using…CertaraMarch 17, 2023
Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients Publication Population pharmacokinetics and limited sampling strategies of polymyxin B in critically ill patients Learn how PopPK modelling supports limited sampling strategies and individualized polymyxin B dosing using Phoenix…CertaraMarch 2, 2023
Simultaneous pharmacokinetic assessment of phytopharmaceuticals in fenugreek extract using LC-MS/MS in Sprague-Dawley rats Publication Simultaneous pharmacokinetic assessment of phytopharmaceuticals in fenugreek extract using LC-MS/MS in Sprague-Dawley rats Simultaneous PK profiling of four fenugreek phytochemicals in rats, supporting development of fenugreek‑based formulations by…CertaraFebruary 27, 2023